The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver Cirrhosis
Abstract
BACKGROUND: Treatment of portal vein thrombosis (PVT) in patients with liver cirrhosis is not well established. AIM: We intended to assess the safety and efficacy of low molecular weight heparin (LMWH) to treat PVT in cirrhotic patients. STUDY: All 39 patients diagnosed with non-neoplastic PVT and cirrhosis from June 2005 to December 2006 were evaluated for anticoagulation therapy (AT). PVT was occludent in 15.4%, partial in 64.1%, and portal cavernoma presented in 20.5%. Twenty-eight patients received 200 U/kg/d of enoxaparin for at least 6 months. In 39.3% of patients PVT was an occasional finding, in 10.7% presented with acute abdominal pain, in 50% with bleeding from gastroesophageal varices. In this last group LMWH was started after endoscopic eradication of varices by band ligation. RESULTS: Complete recanalization of portal vein occurred in 33.3%, partial recanalization in 50% and no response in 16.7% of patients. Further 12 patients who continued AT obtained complete recanalization at a median time of 11 months (range 7 to 17 mo). Overall, a complete response was obtained in 75% of patients. No significant side effects, particularly bleeding complications, were observed during the treatment. CONCLUSIONS: LMWH demonstrated safe and effective in the treatment of PVT in patients with liver cirrhosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Vascular disorders of the liver # †
DeLeve, L. D., Valla, D.-C., & Garcia-Tsao, G. (2009) · Hepatology · doi:10.1002/hep.22772 · Cited by 978
Upper Digestive Bleeding in Cirrhosis. Post–Therapeutic Outcome and Prognostic Indicators
D'Amico, G., & De Franchis, R. (2003) · Hepatology · doi:10.1053/jhep.2003.50385 · Cited by 907
Tripodi, A., Salerno, F., Chantarangkul, V., Clerici, M., Cazzaniga, M., Primignani, M., & Mannuccio Mannucci, P. (2005) · Hepatology · doi:10.1002/hep.20569 · Cited by 696
Yerdel, M. A., Gunson, B., Mirza, D., Karayal??in, K., Olliff, S., Buckels, J., Mayer, D., McMaster, P., & Pirenne, J. (2000) · Transplantation · doi:10.1097/00007890-200005150-00023 · Cited by 694
Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis
Amitrano, L., Anna Guardascione, M., Brancaccio, V., Margaglione, M., Manguso, F., Iannaccone, L., Grandone, E., & Balzano, A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.01.001 · Cited by 582
Self-citationFrancoz, C., Belghiti, J., Vilgrain, V, Sommacale, D., Paradis, V, Condat, B., Denninger, M. H., Sauvanet, A., Valla, D., & Durand, F. (2005) · Gut · doi:10.1136/gut.2004.042796 · Cited by 536
Caldwell, S. H., Hoffman, M., Lisman, T., Macik, B. G., Northup, P. G., Reddy, K. R., Tripodi, A., & Sanyal, A. J. (2006) · Hepatology · doi:10.1002/hep.21303 · Cited by 524
Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy
Condat, B., Pessione, F., Hillaire, S., Denninger, M.-H., Guillin, M.-C., Poliquin, M., Hadengue, A., Erlinger, S., & Valla, D. (2001) · Gastroenterology · doi:10.1053/gast.2001.21209 · Cited by 516
Condat, B., Pessione, F., Denninger, M. H., Hillaire, S., & Valla, D. (2000) · Hepatology · doi:10.1053/jhep.2000.16597 · Cited by 492
Cited by
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
EASL Clinical Practice Guidelines: Vascular diseases of the liver
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.040 · Cited by 808
Northup, P. G., Garcia‐Pagan, J. C., Garcia‐Tsao, G., Intagliata, N. M., Superina, R. A., Roberts, L. N., Lisman, T., & Valla, D. C. (2021) · Hepatology · doi:10.1002/hep.31646 · Cited by 667
Efficacy and Safety of Anticoagulation on Patients With Cirrhosis and Portal Vein Thrombosis
Delgado, M. G., Seijo, S., Yepes, I., Achécar, L., Catalina, M. V., García–Criado, Á., Abraldes, J. G., de la Peña, J., Bañares, R., Albillos, A., et al. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.01.012 · Cited by 379
Metadata
- Authors
- Amitrano, L., Guardascione, M. A., Menchise, A., Martino, R., Scaglione, M., Giovine, S., Romano, L., & Balzano, A.
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2010-07
- Volume
- 44
- Issue
- 6
- Pages
- 448-451
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W2009594394
- Cited by
- 293
- References
- 19
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver Cirrhosis. https://app.cochat.ai/papers/10.1097/mcg.0b013e3181b3ab44
- The paper
- Amitrano, L., Guardascione, M. A., Menchise, A., Martino, R., Scaglione, M., Giovine, S., Romano, L., & Balzano, A. (2010). Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver Cirrhosis. Journal of Clinical Gastroenterology. https://doi.org/10.1097/mcg.0b013e3181b3ab44
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.